Literature DB >> 28426773

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Sara Costa-Cabral, Rachel Brough, Asha Konde, Marieke Aarts, James Campbell, Eliana Marinari, Jenna Riffell, Alberto Bardelli, Christopher Torrance, Christopher J Lord, Alan Ashworth.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0149099.].

Entities:  

Year:  2017        PMID： 28426773      PMCID： PMC5398690          DOI： 10.1371/journal.pone.0176578

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The affiliation for the eighth author is incorrect. Alberto Bartelli is not affiliated with #3 but with #1 The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, SW3 6JB, United Kingdom and #2 Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, United Kingdom.
  1 in total

1.  CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Authors:  Sara Costa-Cabral; Rachel Brough; Asha Konde; Marieke Aarts; James Campbell; Eliana Marinari; Jenna Riffell; Alberto Bardelli; Christopher Torrance; Christopher J Lord; Alan Ashworth
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240
  1 in total
  2 in total

1.  Relationship between CpG island methylation phenotype, microsatellite instability phenotype and mutation of KRAS, NRAS, and BRAF genes in colorectal cancer.

Authors:  Yu Luo; Bo Cheng; Shan Liu; Lin Xu; Xizhao Wu; Suozhu Sun
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

2.  Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Authors:  Sara Costa-Cabral; Rachel Brough; Asha Konde; Marieke Aarts; James Campbell; Eliana Marinari; Jenna Riffell; Alberto Bardelli; Christopher Torrance; Christopher J Lord; Alan Ashworth
Journal:  PLoS One       Date:  2018-10-26       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.